Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0675
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.005 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0675
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

7 Dec 2011 07:00

RNS Number : 4849T
Adventis Group PLC
07 December 2011
 



7 December 2011

 

Adventis Group Plc ("ATG.L")

("Adventis" or the "Group")

 

Disposal of certain assets of Adventis Coltman Limited

 

Adventis is pleased to announce that one of its media buying subsidiaries, Adventis Coltman Limited ("ACL"), has sold its goodwill and order book (the "Assets") to Fundamental Media (UK) Limited ("FMUK") owned 51% by Fundamental Media Limited and 49% by Louise Howse, the former Managing Director of ACL. As part of the disposal, all three of ACL's staff have transferred to FMUK.

 

The disposal was completed on 6 December 2011 and under the terms of the sale agreement between Adventis, ACL and FMUK (the "Sale Agreement") ACL will retain all trade debtors and liabilities which will be realised in due course after which ACL will cease to trade.

 

Under the terms of the Sale Agreement, the consideration payable for the Assets is £75,000 payable in cash on completion. The net proceeds of the sale will be used to reduce the Group's current bank indebtedness.

 

In the year ended 31 December 2010, ACL generated turnover of £7,126,000, net revenues of £710,000 and a profit before tax of £135,000. It is not possible to reliably measure, and therefore disclose, the profit attributable to the Assets from the ACL business as a whole. At 31 December 2010 the Group carried consolidation goodwill of £3,254,000 in relation to ACL which will be written off as a non-cash item in the Group's financial results for the year ending 31 December 2011. The sale of the Assets will reduce the Group's profits. However, following the departure of two key members of staff last month, it was decided that the ACL business was no longer viable and accordingly the Adventis' directors believe that a sale of the Assets and orderly wind down of the business is in the best interests of Adventis' shareholders.

 

Nick Winks, Chairman of Adventis, commented:

 

"This is not a good deal for Adventis other than it is better than the alternative. As two key members of staff had joined a competitor, we were faced with a very rapid decline of the ACL business and accompanying losses. We have rescued what little value we could."

 

 

Enquiries:

 

Adventis Group Plc 01494 731600

Nick Winks, Chairman

Andrew Pearson, Finance Director

 

 

Arbuthnot Securities Limited 020 7012 2000

Tom Griffiths

Rebecca Gordon

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISBIBDDIBGBGBL
Date   Source Headline
2nd Nov 20227:00 amRNSInvestor Presentation
1st Nov 20221:15 pmRNSCompletion of the Sale of Corallian to Shell
31st Oct 20229:08 amRNSPosting of Circular and Notice of Requisitioned GM
31st Oct 20227:00 amRNSPosting of Circular and Notice of Requisitioned GM
20th Oct 20227:00 amRNSRequisition of General Meeting
17th Oct 20221:00 pmRNSPurported Requisition of General Meeting
5th Oct 20223:30 pmRNSSPA for Sale of Corallian to Shell for £32 million
30th Sep 20227:00 amRNSUnaudited HY Results for 6 months ended 30/06/22
29th Sep 20227:02 amRNSPublication of PEDL183 CPR by RPS Energy
28th Sep 20227:00 amRNSConditional Acquisition of Simwell Resources
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
15th Sep 20227:00 amRNSAcquisition of North Sea Assets from Corallian
14th Sep 20227:00 amRNSAgreed Terms of Conditional Sale of Corallian
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
9th Sep 20227:00 amRNSResponse to Governmental Energy Plan
1st Sep 20227:00 amRNSUpdate on Corallian and acquisition of licences
14th Jul 20221:56 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSBoard Change
29th Jun 20224:31 pmRNSResults of Annual General Meeting
23rd Jun 20227:00 amRNSInvestor Presentation
21st Jun 20227:00 amRNSWest Newton Conceptual Development Plan
7th Jun 202211:53 amRNSNotice of AGM – correction of typographical error
1st Jun 202210:06 amRNSNotice of Annual General Meeting
27th May 20227:00 amRNSFull Year Results for the year ended 31 Dec 2021
26th May 20227:00 amRNSCompletion of Equity Exchange Agreement
24th May 20227:00 amRNSReabold North Sea – Presentation on New Licences
23rd May 20227:00 amRNSShareholder Approval Received for Equity Exchange
13th May 20227:00 amRNSAppointment of Chief Financial Officer
4th May 20227:00 amRNSOffer for Corallian and acquisition of licences
3rd May 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
17th Mar 202212:21 pmRNSPlanning Application Approval for Next Phase
25th Feb 20227:00 amRNSInvestor Presentation
25th Feb 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
24th Feb 20224:42 pmRNSSecond Price Monitoring Extn
24th Feb 20224:37 pmRNSPrice Monitoring Extension
17th Feb 202212:38 pmRNSAmendment of Existing Option Terms
25th Jan 20229:05 amRNSSecond Price Monitoring Extn
25th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn
20th Oct 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.